🇺🇸 Neulasta in United States

62,125 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Device Adhesion Issue — 11,340 reports (18.25%)
  2. Wrong Technique In Product Usage Process — 10,192 reports (16.41%)
  3. Unintentional Medical Device Removal — 8,928 reports (14.37%)
  4. Device Malfunction — 6,701 reports (10.79%)
  5. Device Use Error — 6,017 reports (9.69%)
  6. Device Issue — 5,037 reports (8.11%)
  7. Accidental Exposure To Product — 4,934 reports (7.94%)
  8. Device Occlusion — 3,202 reports (5.15%)
  9. Off Label Use — 3,025 reports (4.87%)
  10. Bone Pain — 2,749 reports (4.42%)

Source database →

Other Hematology approved in United States

Frequently asked questions

Is Neulasta approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Neulasta in United States?

Columbia University is the originator. The local marketing authorisation holder may differ — check the official source linked above.